New York Health Policy Monitor (September 29, 2026)
The Department of Labor proposes regulations regarding opioid antagonist protocols in the workplace, expanding employer compliance frameworks.
The Department of Labor initiated a regulatory action to establish specific overdose response requirements in the workplace. If finalized, this measure would mandate that private employers subject to federal OSHA first-aid requirements maintain an accessible supply of overdose reversal medications, such as naloxone. The proposed rule making relies on authority granted by Labor Law Section 27-f, shifting public health interventions directly into broad commercial and industrial employment settings.
State regulatory agencies continue to integrate substance use disorder responses into standard occupational safety mandates. Under the proposal, facilities will need to alter their current physical plant standards and emergency response policies to accommodate the required on-site availability of opioid antagonists, ensuring they are not locked away or restricted. Furthermore, employers will face a new staffing compliance burden, as they must ensure at least one trained employee is on-site to administer the medication during all business hours.
As this proposal advances through the regulatory process, stakeholders across the employment spectrum must evaluate the mechanical friction of implementing these standardized protocols. Affected private entities should review their internal policies, occupational safety oversight procedures, and training modules to assess compliance readiness if the regulations are ultimately adopted.
Priority Items
Affected Entities and Corresponding Policies
- Employers: LAB-38-26-00001-P
- Occupational Health Facilities: LAB-38-26-00001-P
- Substance Use Disorder Providers: LAB-38-26-00001-P
Prepared by Isaac Michaels, DrPH · September 29, 2026